Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Nautilus Biotechnology, Inc. NAUT
$2.48
+$0.05 (2.06%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
298429740.00000000
-
week52high
4.01
-
week52low
1.50
-
Revenue
0
-
P/E TTM
-4811
-
Beta
0.80987900
-
EPS
-0.41000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 мая 2023 г. в 12:30
Описание компании
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 03 авг 2022 г. |
| Goldman Sachs | Neutral | Neutral | 03 авг 2022 г. |
| Goldman Sachs | Neutral | Neutral | 14 июл 2022 г. |
| Goldman Sachs | Neutral | Neutral | 13 апр 2022 г. |
| Morgan Stanley | Equal-Weight | 06 янв 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sankar Subramanian | A | 91250 | 5000 | 27 сент 2022 г. |
| Sankar Subramanian | A | 86250 | 10000 | 26 сент 2022 г. |
| Weld Gwen E | A | 30000 | 30000 | 23 сент 2022 г. |
| Sankar Subramanian | A | 75000 | 35000 | 16 сент 2022 г. |
| Sankar Subramanian | A | 40000 | 40000 | 15 сент 2022 г. |
| Mowry Anna | A | 56750 | 17500 | 19 авг 2022 г. |
| Murphy Matthew B. | A | 54140 | 7500 | 15 авг 2022 г. |
| Murphy Matthew B. | A | 46640 | 2500 | 12 авг 2022 г. |
| Patel Sujal M | A | 10014488 | 8346 | 08 авг 2022 г. |
| Patel Sujal M | A | 10006142 | 41654 | 05 авг 2022 г. |
Новостная лента
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
GlobeNewsWire
26 янв 2023 г. в 08:00
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, February 23, 2023.
Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript
Seeking Alpha
01 ноя 2022 г. в 14:35
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Sujal Patel - Co-Founder and CEO Parag Mallick - Co-Founder and Chief Scientist Anna Mowry - CFO Conference Call Participants Max Masucci - Cowen David Delahunt - Goldman Sachs Brandon Couillard - Jefferies Operator Ladies and gentlemen, thank you for standing by, and welcome to the Nautilus Q3 2022 Earnings Call. [Operator Instructions] I would now like to turn the call over to your host [Alex Khan], Investor Relations.
Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewsWire
30 авг 2022 г. в 08:00
SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
02 авг 2022 г. в 12:02
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Sujal Patel - Founder and Chief Executive Officer Anna Mowry - Chief Financial Officer Parag Mallick - Founder and Chief Scientist Conference Call Participants Stephanie Yan - Cowen and Company, LLC Tejas Savant - Morgan Stanley David Delahunt - Goldman Sachs Operator Thank you for standing by, and welcome to the Nautilus Biotechnology Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha
03 мая 2022 г. в 12:21
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Sujal Patel - Co-Founder & CEO Anna Mowry - CFO Parag Mallick - Co-Founder & Chief Scientific Officer Conference Call Participants Matt Kim - Jefferies Stephanie Yan - Cowen & Company Edmund Tu - Morgan Stanley David Delahunt - Goldman Sachs Operator Thank you for standing by, and welcome to the Nautilus Q1 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.